TRACON To Report Third Quarter 2016 Company Highlights And Financial Results On November 8, 2016

SAN DIEGO, Nov. 01, 2016 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, wet age-related macular degeneration and fibrotic diseases, announced today that it will report its third quarter 2016 financial and operating results after the close of U.S. financial markets on Tuesday, November 8, 2016. In addition, management will host a conference call to provide an update on corporate activities and discuss the quarterly financial results.
Conference call and webcast:
Date: November 8, 2016
Time: 4:30 pm Eastern Time (1:30 pm Pacific Time)
Dial-in: (855) 779-9066 (Domestic) or (631) 485-4859 (International)
Passcode: 10003680
Via web: www.traconpharma.com; "Events and Presentation" section within the "Investors" section

A replay of the webcast will be available for 60 days on the website.

About TRACON

TRACON develops targeted therapies for cancer, ophthalmic and fibrotic diseases. The Company's clinical-stage pipeline includes: TRC105, an endoglin antibody that is being developed for the treatment of multiple cancers; DE-122, the ophthalmic formulation of TRC105 that is being developed in wet AMD through a collaboration with Santen Pharmaceutical Company Ltd.; and TRC102, a small molecule that is being developed for the treatment of lung cancer and glioblastoma. To learn more about TRACON and its product candidates, visit TRACON's website at www.traconpharma.com.

Company Contact:Casey LoganChief Business Officer(858) 550-0780 ext. 236clogan@traconpharma.comInvestor Contact:Andrew McDonaldLifeSci Advisors LLC646-597-6987Andrew@lifesciadvisors.com

Primary Logo

If you liked this article you might like

6 Stocks Spiking on Big Volume

6 Stocks Spiking on Big Volume

IPO Roundup: Shake Shack Shares More Than Double Out of Gate

IPO Roundup: Shake Shack Shares More Than Double Out of Gate